Syncromune Employee Directory

Syncromune corporate office is located in 2919 E Commercial Blvd, Fort Lauderdale, Florida, 33308, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Medical & Health

12

Engineering & Technical

7

C-Suite

6

Operations

5

Legal

4

Finance

3

Marketing

3

Syncromune CEO

JL
United States flag for contact location.
Jonathan LewisChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Syncromune

Syncromune Global Presence

globalPresence illustration
North America11-50
Europe1-10

Index of contact profiles from Syncromune

Hundreds of professionals searching for Syncromune have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Syncromune

Explore people who held key positions, contributed to Syncromune's success, and advanced their careers.

  1. Principal Consultant at 1130 Works

    Worked as Senior VP, Human Resources

    at Syncromune

    email Francie Babik Email direct Francie Babik Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Florida, United States

Frequently Asked Questions Regarding Syncromune Employees

How many employees does Syncromune have?
Syncromune has 11-50 employees
Who is the CEO of Syncromune?
Syncromune’s CEO is Jonathan Lewis
Who is the CFO of Syncromune?
Syncromune’s CFO is Kerri-Ann Millar
Who are Syncromune key employees?
Some of Syncromune key employees are Kerri-Ann Millar, Stephen Dale
Where is Syncromune located?
Syncromune’s headquarters are located at 2919 E Commercial Blvd, Fort Lauderdale, Florida, 33308, United States
How do I contact Syncromune?
Syncromune Contact Info: Website: www.syncromune.com
What does Syncromune do?

Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of an in situ platform therapy optimized for metastatic solid tumor cancers that aims to achieve high response rates with potentially improved survival. The company is currently developing SYNC-T, a novel and personalized in situ therapy that combi... nes partial tumor oncolysis and a multi-target biologic drug. The SYNC-T combination approach is designed to target multiple mechanisms of cancer, promoting in situ immune activation while battling immunosuppression. The goal is to activate T cells, enabling the immune system to recognize and attack cancer throughout the body and defend with immune memory. The first two candidates, SV-101 and SV-102, are currently in Phase 1 trials.Read More

Is Syncromune a public company?
Syncromune is private company therefore does not currently have an official ticker symbol
See more information about Syncromune Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.